John Paulson’s portfolio: Paulson & Co 13F holdings
Quarterly SEC 13F-HR filingsCIK 0001035674Latest: Q2 2026
Q3 2017 filing in brief
In its Q3 2017 13F, filed November 14, 2017, Paulson & Co reported $5.6B across 54 US positions. The largest: GLD (9.5%), SHIRE PLC (8.7%), MYLAN N V (8.3%), ALLERGAN PLC (8.0%), TMUS (5.8%). In the quarter it opened 6 positions, sold out of 61, added to 5 and trimmed 17; positions opened and sold out came to 14.8% of the portfolio's value.
Methodology
Holdings come from the manager’s Form 13F-HR filings on SEC EDGAR, with amendments applied. Values and shares are reported at quarter-end; the filing date is when the report became public. These disclosures show reported long positions and listed options, not the manager’s entire portfolio or its trades since quarter-end.
Quarterly changes compare shares with the immediately preceding quarter on file. New and exited positions appear or disappear; added and trimmed positions change their share count by more than 1%. A share change can also reflect a stock split or other corporate action.
Opened and sold out is the value of new positions plus the prior value of exited positions, divided by the average of the two quarters’ reported portfolio values. It excludes changes to positions still held. Reported value growth includes price changes and is not a measure of investment performance. Largest-five and largest-ten weights exclude options.
Holdings
Filed Nov 14, 2017
- 6 New
- 5 Added
- 17 Trimmed
- 61 Exited
54 positions at September 30, 2017. Q/Q change compares shares with the preceding quarter.
| Row | Ticker | Issuer | Status | ||||
|---|---|---|---|---|---|---|---|
| 1 | GLD | SPDR GOLD TRUST | $530M | 4.4M | 9.52% | 0.0% | Held |
| 2 | — | SHIRE PLC | $483M | 3.2M | 8.67% | −9.4% | Trimmed |
| 3 | — | MYLAN N V | $462M | 14.7M | 8.29% | −7.6% | Trimmed |
| 4 | — | ALLERGAN PLC | $447M | 2.2M | 8.02% | −19.4% | Trimmed |
| 5 | TMUS | T MOBILE US INC | $321M | 5.2M | 5.76% | −14.1% | Trimmed |
| 6 | — | VALEANT PHARMACEUTICALS INTL | $299M | 20.8M | 5.36% | −4.5% | Trimmed |
| 7 | — | CAESARS ACQUISITION CO | $281M | 13.1M | 5.05% | 0.0% | Held |
| 8 | DISH | DISH NETWORK CORP | $254M | 4.7M | 4.55% | +17.0% | Added |
| 9 | AABAUSD | ALTABA INC | $252M | 3.8M | 4.52% | +42.0% | Added |
| 10 | TWXCHF | TIME WARNER INC | $249M | 2.4M | 4.46% | −18.8% | Trimmed |
| 11 | — | MALLINCKRODT PUB LTD CO | $248M | 6.6M | 4.45% | −3.8% | Trimmed |
| 12 | VST | VISTRA ENERGY CORP | $216M | 11.5M | 3.87% | 0.0% | Held |
| 13 | CZR | CAESARS ENTMT CORP | $192M | 14.4M | 3.46% | 0.0% | Held |
| 14 | AU3EUR | ANGLOGOLD ASHANTI LTD | $119M | 12.8M | 2.13% | 0.0% | Held |
| 15 | TSU | TIM PARTICIPACOES S A | $101M | 5.6M | 1.82% | 0.0% | Held |
| 16 | NG | NOVAGOLD RES INC | $91M | 22.0M | 1.63% | 0.0% | Held |
| 17 | — | BANK AMER CORP | $83M | 6.3M | 1.49% | 0.0% | Held |
| 18 | — | HORIZON PHARMA PLC | $71M | 5.6M | 1.27% | +13.0% | Added |
| 19 | — | SYNERGY PHARMACEUTICALS DEL | $70M | 24.1M | 1.25% | −0.1% | Held |
| 20 | — | INTERNATIONAL SEAWAYS INC | $68M | 3.5M | 1.22% | 0.0% | Held |
| 21 | — | ENDO INTL PLC | $61M | 7.2M | 1.10% | 0.0% | Held |
| 22 | BKD | BROOKDALE SR LIVING INC | $53M | 5.0M | 0.95% | 0.0% | Held |
| 23 | ODPEUR | OFFICE DEPOT INC | $45M | 10.0M | 0.81% | −20.7% | Trimmed |
| 24 | OASEUR | OASIS PETE INC NEW | $44M | 4.9M | 0.80% | −0.1% | Held |
| 25 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $43M | 2.5M | 0.77% | −63.7% | Trimmed |
| 26 | — | RANDGOLD RES LTD | $42M | 431.7K | 0.76% | 0.0% | Held |
| 27 | CIEI 3.125 05/15/24 | COBALT INTL ENERGY INC | $42M | 219.2M | 0.75% | 0.0% | Held |
| 28 | STAYUSD | EXTENDED STAY AMER INC | $36M | 1.8M | 0.65% | 0.0% | Held |
| 29 | AEM | AGNICO EAGLE MINES LTD | $34M | 757.6K | 0.61% | 0.0% | Held |
| 30 | — | REALOGY HLDGS CORP | $33M | 1.0M | 0.59% | −75.0% | Trimmed |
| 31 | THM | INTERNATIONAL TOWER HILL MIN | $30M | 55.5M | 0.53% | 0.0% | Held |
| 32 | — | MONSANTO CO NEW | $26M | 217.4K | 0.47% | +36.6% | Added |
| 33 | — | CALPINE CORP | $25M | 1.7M | 0.45% | — | New |
| 34 | — | ENZYMOTEC LTD | $24M | 2.1M | 0.43% | −50.0% | Trimmed |
| 35 | IAG | IAMGOLD CORP | $24M | 3.9M | 0.42% | 0.0% | Held |
| 36 | EQT | EQT CORP | $19M | 293.0K | 0.34% | — | New |
| 37 | BCRUSD | BARD C R INC | $19M | 58.7K | 0.34% | +39.4% | Added |
| 38 | — | SPRINT CORP | $18M | 2.4M | 0.33% | — | New |
| 39 | — | XCERRA CORP | $17M | 1.7M | 0.31% | −31.3% | Trimmed |
| 40 | — | ROCKWELL COLLINS INC | $15M | 112.4K | 0.26% | — | New |
| 41 | SD | SANDRIDGE ENERGY INC | $13M | 666.5K | 0.24% | 0.0% | Held |
| 42 | TMQ | TRILOGY METALS INC NEW | $11M | 11.6M | 0.20% | 0.0% | Held |
| 43 | TGNA | TEGNA INC | $10M | 778.3K | 0.19% | 0.0% | Held |
| 44 | DOVA | DOVA PHARMACEUTICALS INC | $10M | 550.7K | 0.18% | −11.4% | Trimmed |
| 45 | SA | SEABRIDGE GOLD INC | $9M | 700.0K | 0.15% | 0.0% | Held |
| 46 | BOBEUSD | BOB EVANS FARMS INC | $8M | 106.0K | 0.15% | — | New |
| 47 | — | BANK AMER CORP | $7M | 8.9M | 0.13% | 0.0% | Held |
| 48 | — | SYNTHESIS ENERGY SYS INC | $5M | 10.0M | 0.10% | 0.0% | Held |
| 49 | — | KAMADA LTD | $4M | 730.8K | 0.06% | −7.6% | Trimmed |
| 50 | CIE1EUR | COBALT INTL ENERGY INC | $3M | 2.0M | 0.05% | −0.1% | Held |
| 51 | IEF | ISHARES TR | $2M | 20.0K | 0.04% | — | New |
| 52 | — | LOXO ONCOLOGY INC | $2M | 22.8K | 0.04% | −96.7% | Trimmed |
| 53 | — | NXP SEMICONDUCTORS N V | $1M | 12.5K | 0.03% | −99.0% | Trimmed |
| 54 | HUN | HUNTSMAN CORP | $137K | 5.0K | 0.00% | −61.5% | Trimmed |
61 exited positions
Positions held in the preceding quarter and absent from this filing. Values and shares are from the preceding quarter.
| Ticker | Issuer | Previous value | Previous shares |
|---|---|---|---|
| AIG | AMERICAN INTL GROUP INC | $259M | 4.1M |
| — | VWR CORP | $88M | 2.7M |
| WLHUSD | LYON WILLIAM HOMES | $80M | 3.3M |
| HTZ-WEUR | HERTZ GLOBAL HLDGS INCput option | $29M | 2.5M |
| ALXN | ALEXION PHARMACEUTICALS INCcall option | $24M | 200.0K |
| META | FACEBOOK INC | $22M | 144.5K |
| — | SHIRE PLCcall option | $21M | 125.0K |
| ARNCCHF | ARCONIC INC | $20M | 897.5K |
| — | MOBILEYE N V AMSTELVEEN | $17M | 272.6K |
| FDX | FEDEX CORP | $16M | 75.4K |
| XENTEUR | INTERSECT ENT INC | $16M | 558.0K |
| — | REYNOLDS AMERICAN INC | $15M | 236.8K |
| NEWREUR | NEW RELIC INC | $15M | 353.3K |
| — | ATLASSIAN CORP PLC | $14M | 397.9K |
| DXCM | DEXCOM INC | $13M | 183.4K |
| TIME1EUR | TIME INC NEW | $13M | 887.2K |
| ALXN | ALEXION PHARMACEUTICALS INC | $13M | 103.2K |
| — | GLAXOSMITHKLINE PLC | $12M | 289.5K |
| PANW | PALO ALTO NETWORKS INC | $11M | 80.1K |
| — | STERIS PLC | $11M | 131.5K |
| SNAP | SNAP INCput option | $10M | 580.0K |
| — | ESPERION THERAPEUTICS INC NE | $10M | 210.5K |
| ISRG | INTUITIVE SURGICAL INC | $10M | 10.2K |
| CTRPUSD | CTRIP COM INTL LTD | $9M | 173.2K |
| — | SPECTRANETICS CORP | $9M | 237.5K |
| HCA | HCA HEALTHCARE INC | $8M | 90.0K |
| Z | ZILLOW GROUP INC | $8M | 160.0K |
| — | MYLAN N Vcall option | $8M | 200.0K |
| AMZN | AMAZON COM INC | $8M | 7.8K |
| MGIEUR | MONEYGRAM INTL INC | $8M | 435.9K |
| SERV | SERVICEMASTER GLOBAL HLDGS I | $7M | 174.0K |
| — | ALBANY MOLECULAR RESH INC | $7M | 314.2K |
| DVAX | DYNAVAX TECHNOLOGIES CORP | $5M | 554.6K |
| COR1EUR | CORESITE RLTY CORP | $5M | 49.0K |
| MELI | MERCADOLIBRE INC | $5M | 20.0K |
| GRFS | GRIFOLS S A | $4M | 196.8K |
| — | WEBMD HEALTH CORP | $4M | 64.7K |
| WDAY | WORKDAY INC | $4M | 38.6K |
| GOOG | ALPHABET INC | $4M | 4.0K |
| CYH | COMMUNITY HEALTH SYS INC NEWput option | $3M | 340.0K |
| 2655787D | BLUEPRINT MEDICINES CORP | $3M | 65.8K |
| — | K2M GROUP HLDGS INC | $3M | 109.6K |
| SNY | SANOFI | $2M | 52.0K |
| PBYI | PUMA BIOTECHNOLOGY INC | $2M | 27.5K |
| BCRX | BIOCRYST PHARMACEUTICALS | $2M | 349.5K |
| RIGL | RIGEL PHARMACEUTICALS INC | $2M | 662.1K |
| AAPL | APPLE INC | $2M | 12.3K |
| — | ENTELLUS MED INC | $2M | 102.7K |
| IMGNEUR | IMMUNOGEN INC | $2M | 229.2K |
| HALO | HALOZYME THERAPEUTICS INC | $1M | 111.1K |
| PODD | INSULET CORP | $1M | 25.0K |
| — | IGNYTA INC | $1M | 123.0K |
| MULEUSD | MULESOFT INC | $1M | 43.0K |
| — | TREVENA INC | $938K | 407.6K |
| EDIT | EDITAS MEDICINE INC | $839K | 50.0K |
| NTLA | INTELLIA THERAPEUTICS INC | $778K | 48.6K |
| SIENUSD | SIENTRA INC | $776K | 79.8K |
| — | CRISPR THERAPEUTICS AG | $457K | 28.5K |
| — | TANDEM DIABETES CARE INC | $400K | 500.0K |
| ARDMEUR | ARADIGM CORP | $252K | 192.7K |
| OKTA | OKTA INC | $171K | 7.5K |
Every quarter on file (53)
From the manager’s Form 13F-HR filings on SEC EDGAR, amendments applied. Long US positions only; not a recommendation.